A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache
- Conditions
- Episodic Cluster Headache
- Registration Number
- NCT00033839
- Lead Sponsor
- Winston Laboratories
- Brief Summary
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (26)
Valley Neurological Headache & Research Center
🇺🇸Phoenix, Arizona, United States
Neurological Associates of Tucson
🇺🇸Tucson, Arizona, United States
Northern California Headache Clinic
🇺🇸Mountain View, California, United States
San Francisco Clinical Research Center
🇺🇸San Francisco, California, United States
California Medical Clinic for Headache
🇺🇸Santa Monica, California, United States
New England Center for Headache, PC
🇺🇸Stamford, Connecticut, United States
Neurology Clinical Research, Inc.
🇺🇸Plantation, Florida, United States
Neurology and Headache Specialists of Atlanta
🇺🇸Decatur, Georgia, United States
Diamond Headache Clinic
🇺🇸Chicago, Illinois, United States
Boston Clinical Research Center
🇺🇸Wellesley Hills, Massachusetts, United States
Scroll for more (16 remaining)Valley Neurological Headache & Research Center🇺🇸Phoenix, Arizona, United States